Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9459 | 0.89 | — | — | |
| SCHEMBL2094168 | 0.89 | LMNA (1.00) | LMNATHRB | |
| Hydroxyamine SCHEMBL7122122 | 0.87 | LMNA (0.80) | LMNATHRB | |
| SCHEMBL9518993 | 0.86 | — | — | |
| SCHEMBL10435620 | 0.86 | — | — | |
| Hydrogen Sulfide SCHEMBL3719386 | 0.86 | — | — | |
| SCHEMBL11207256 | 0.86 | — | — | |
| SCHEMBL3453066 | 0.86 | — | — | |
| Ammonia Solution, Strong SCHEMBL15232243 | 0.86 | LMNA (0.92) | LMNATHRB | |
| SCHEMBL5105333 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2323996-B1 | LUMINOGENIC COMPOUNDS AND METHODS TO DETECT CYTOCHROME P450 3A ENZYMES | PROMEGA CORP (US) | 2014-10-22 | — | — | EP | disclosed |
| US-8288559-B2 | Luminogenic compounds and methods to detect cytochrome P450 3A enzymes | PROMEGA CORPORATION (US) | 2012-10-16 | — | — | US | disclosed |
| EP-2323996-A1 | LUMINOGENIC COMPOUNDS AND METHODS TO DETECT CYTOCHROME P450 3A ENZYMES | Promega Corporation (US) | 2011-05-25 | — | — | EP | disclosed |
| US-20100062470-A1 | LUMINOGENIC COMPOUNDS AND METHODS TO DETECT CYTOCHROME P450 3A ENZYMES | PROMEGA CORPORATION (US) | 2010-03-11 | — | — | US | disclosed |
| WO-2010021686-A1 | LUMINOGENIC COMPOUNDS AND METHODS TO DETECT CYTOCHROME P450 3A ENZYMES | PROMEGA CORPORATION (US) | 2010-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100062470-A1 | LUMINOGENIC COMPOUNDS AND METHODS TO DETECT CYTOCHROME P450 3A ENZYMES | CYP3A43, CYP1A1, CYP3A4 | LMNA 1683/4885THRB 3493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.